marianvejcik-istockphoto-com-gavel-uk--1
marianvejcik / iStockphoto.com
20 September 2018Europe

Gilead HIV drug not entitled to SPC, says UK court

The English High Court has ruled that Gilead’s drug Truvada is not entitled to a supplementary protection certificate (SPC) because it failed to meet the standards set out by Europe’s highest court earlier this year.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
23 August 2018   A non-profit called AIDS Healthcare Foundation has filed a petition for certiorari with the US Supreme Court in a patent dispute with Gilead.
Big Pharma
4 June 2018   The Paris Court of First Instance has nullified a supplementary protection certificate covering Gilead’s HIV/AIDS treatment Truvada.

More on this story

Americas
23 August 2018   A non-profit called AIDS Healthcare Foundation has filed a petition for certiorari with the US Supreme Court in a patent dispute with Gilead.
Big Pharma
4 June 2018   The Paris Court of First Instance has nullified a supplementary protection certificate covering Gilead’s HIV/AIDS treatment Truvada.

More on this story

Americas
23 August 2018   A non-profit called AIDS Healthcare Foundation has filed a petition for certiorari with the US Supreme Court in a patent dispute with Gilead.
Big Pharma
4 June 2018   The Paris Court of First Instance has nullified a supplementary protection certificate covering Gilead’s HIV/AIDS treatment Truvada.